Pathogenic diversification of the gut commensal <i>Providencia alcalifaciens</i> via acquisition of a second type III secretion system
<i>Providencia alcalifaciens</i> is a Gram-negative bacterium found in various water and land environments and organisms, including insects and mammals. Some <i>P. alcalifaciens</i> strains encode gene homologs of virulence factors found in pathogenic Enterobacterales members, such as <i>Salmonella enterica</i> serovar Typhimurium and <i>Shigella flexneri</i>. Whether these genes are pathogenic determinants in <i>P. alcalifaciens</i> is not known. In this study, we investigated <i>P. alcalifaciens</i>-host interactions at the cellular level, focusing on the role of two type III secretion systems (T3SS) belonging to the Inv-Mxi/Spa family. T3SS<sub>1b</sub> is widespread in <i>Providencia</i> spp. and encoded on the chromosome. A large plasmid that is present in a subset of <i>P. alcalifaciens</i> strains, primarily isolated from diarrheal patients, encodes for T3SS<sub>1a</sub>. We show that <i>P. alcalifaciens</i> 205/92 is internalized into eukaryotic cells, lyses its internalization vacuole, and proliferates in the cytosol. This triggers caspase-4-dependent inflammasome responses in gut epithelial cells. The requirement for the T3SS<sub>1a</sub> in entry, vacuole lysis, and cytosolic proliferation is host cell type-specific, playing a more prominent role in intestinal epithelial cells than in macrophages or insect cells. In a bovine ligated intestinal loop model, <i>P. alcalifaciens</i> colonizes the intestinal mucosa and induces mild epithelial damage with negligible fluid accumulation in a T3SS<sub>1a</sub>- and T3SS<sub>1b</sub>-independent manner. However, T3SS<sub>1b</sub> was required for the rapid killing of <i>Drosophila melanogaster</i>. We propose that the acquisition of two T3SS has allowed <i>P. alcalifaciens</i> to diversify its host range, from a highly virulent pathogen of insects to an opportunistic gastrointestinal pathogen of animals.
Authors
- Leigh A. Knodler (ORCID: https://orcid.org/0000-0002-3028-2198)
- Amanda L. Haeberle (ORCID: https://orcid.org/0009-0004-8407-891X)
- Sarah J Wright (ORCID: https://orcid.org/0000-0002-1502-131X)
- Jessica A. Klein (ORCID: https://orcid.org/0000-0002-0529-9406)
- Bruce A. Vallance (ORCID: https://orcid.org/0000-0003-1345-6747)
- Johanna R. Elfenbein (ORCID: https://orcid.org/0000-0002-4764-0713)
- Jennifer A. Cundiff (ORCID: https://orcid.org/0000-0002-3955-8226)
- Alexander V. Predeus (ORCID: https://orcid.org/0000-0002-2750-1599)
- Marie Wrande
- Alan G. Goodman (ORCID: https://orcid.org/0000-0001-6394-332X)
- Donna J. Robinson
- Michael McClelland (ORCID: https://orcid.org/0000-0003-1788-9347)
- Andrés Mejía (ORCID: https://orcid.org/0000-0001-6088-3595)
- Aimee R. Greissl
- Mattie M. Clark-Herrera
- Aaditi Lele
- Nicole Green (ORCID: https://orcid.org/0000-0001-9745-0240)
- Eddy Cruz
- Trina L. Westerman
- Maya Howell
Institutions
- University of Vermont (US)
- Los Angeles County Department of Public Health (US)
- University of Wisconsin–Madison (US)
- North Carolina State University (US)
- University of British Columbia (CA)
- University of California, Irvine (US)
- Wellcome Sanger Institute (GB)
- BC Children's Hospital (CA)
- Washington State University (US)
Publication Details
- Journal
- Infection and Immunity
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1128/iai.00314-24
- Citations
- 9
- Primary Topic
- Vibrio bacteria research studies
- Type
- article
- Field-Weighted Citation Impact
- 5.56
Funders
- Washington State University
- National Institutes of Health
- Genentech
- National Institute of Allergy and Infectious Diseases